Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GK.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.16.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.13.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.13.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.5.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JY.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.16.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.7.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.7.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used